Sana Biotechnology Prices Upsized Public Offering Of $165 Mln Of Shares

(RTTNews) – Sana Biotechnology, Inc. (SANA) announced Thursday that it has priced its underwritten public offering of 17,272,728 shares at $5.50 per share and, in lieu of shares to certain investors, warrants of pre-funded subscriptions to purchase 12,727,272 shares at $5.4999 per pre-funded mandate.

Proceeds from the offering, which will close on or about February 12, are expected to be approximately $165 million.

The Company has granted the underwriters a 30-day option to purchase up to 4,500,000 additional shares.

Sana will sell all pre-funded shares and warrants.

Morgan Stanley, JP Morgan, Goldman Sachs & Co. LLC and BofA Securities are acting as joint book-running managers for the offering.

Source link

Scroll to Top